List of Tables
    Table 1. Meningococcal Disease Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Meningococcal Disease Treatment Market Trends
    Table 3. Meningococcal Disease Treatment Market Drivers
    Table 4. Meningococcal Disease Treatment Market Challenges
    Table 5. Meningococcal Disease Treatment Market Restraints
    Table 6. Global Meningococcal Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Meningococcal Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Meningococcal Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Meningococcal Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Meningococcal Disease Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Meningococcal Disease Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Meningococcal Disease Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Meningococcal Disease Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Meningococcal Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Disease Treatment as of 2021)
    Table 15. Top Players of Meningococcal Disease Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Meningococcal Disease Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Meningococcal Disease Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Meningococcal Disease Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Meningococcal Disease Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Meningococcal Disease Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Meningococcal Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Meningococcal Disease Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Meningococcal Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Meningococcal Disease Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Meningococcal Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Meningococcal Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Meningococcal Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Meningococcal Disease Treatment Product
    Table 33. Pfizer Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. GlaxoSmithKline Company Details
    Table 36. GlaxoSmithKline Business Overview
    Table 37. GlaxoSmithKline Meningococcal Disease Treatment Product
    Table 38. GlaxoSmithKline Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 39. GlaxoSmithKline Recent Development
    Table 40. Sanofi Pasteur Company Details
    Table 41. Sanofi Pasteur Business Overview
    Table 42. Sanofi Pasteur Meningococcal Disease Treatment Product
    Table 43. Sanofi Pasteur Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 44. Sanofi Pasteur Recent Development
    Table 45. Novartis Company Details
    Table 46. Novartis Business Overview
    Table 47. Novartis Meningococcal Disease Treatment Product
    Table 48. Novartis Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 49. Novartis Recent Development
    Table 50. CanSino Biologics Inc. Company Details
    Table 51. CanSino Biologics Inc. Business Overview
    Table 52. CanSino Biologics Inc. Meningococcal Disease Treatment Product
    Table 53. CanSino Biologics Inc. Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 54. CanSino Biologics Inc. Recent Development
    Table 55. Merck Sharp & Dohme Company Details
    Table 56. Merck Sharp & Dohme Business Overview
    Table 57. Merck Sharp & Dohme Meningococcal Disease Treatment Product
    Table 58. Merck Sharp & Dohme Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 59. Merck Sharp & Dohme Recent Development
    Table 60. Beijing Minhai Biological Technology Co.,Ltd. Company Details
    Table 61. Beijing Minhai Biological Technology Co.,Ltd. Business Overview
    Table 62. Beijing Minhai Biological Technology Co.,Ltd. Meningococcal Disease Treatment Product
    Table 63. Beijing Minhai Biological Technology Co.,Ltd. Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 64. Beijing Minhai Biological Technology Co.,Ltd. Recent Development
    Table 65. Walvax Biotechnology Co.,Ltd. Company Details
    Table 66. Walvax Biotechnology Co.,Ltd. Business Overview
    Table 67. Walvax Biotechnology Co.,Ltd. Meningococcal Disease Treatment Product
    Table 68. Walvax Biotechnology Co.,Ltd. Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 69. Walvax Biotechnology Co.,Ltd. Recent Development
    Table 70. Chengdu Institute of Biology Company Details
    Table 71. Chengdu Institute of Biology Business Overview
    Table 72. Chengdu Institute of Biology Meningococcal Disease Treatment Product
    Table 73. Chengdu Institute of Biology Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 74. Chengdu Institute of Biology Recent Development
    Table 75. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Company Details
    Table 76. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Business Overview
    Table 77. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Treatment Product
    Table 78. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 79. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Recent Development
    Table 80. Shandong Jincheng Pharmaceutical Group Co.,ltd. Company Details
    Table 81. Shandong Jincheng Pharmaceutical Group Co.,ltd. Business Overview
    Table 82. Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Treatment Product
    Table 83. Shandong Jincheng Pharmaceutical Group Co.,ltd. Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 84. Shandong Jincheng Pharmaceutical Group Co.,ltd. Recent Development
    Table 85. Apeloa Pharmaceutical Co.,Ltd. Company Details
    Table 86. Apeloa Pharmaceutical Co.,Ltd. Business Overview
    Table 87. Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Treatment Product
    Table 88. Apeloa Pharmaceutical Co.,Ltd. Revenue in Meningococcal Disease Treatment Business (2017-2022) & (US$ Million)
    Table 89. Apeloa Pharmaceutical Co.,Ltd. Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Meningococcal Disease Treatment Product Picture
    Figure 2. Global Meningococcal Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Meningococcal Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Meningococcal Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Meningococcal Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Meningococcal Disease Treatment Market Share in Global 2017-2028
    Figure 7. Meningococcal Disease Treatment Report Years Considered
    Figure 8. Product Picture of Antibiotics
    Figure 9. Product Picture of Vaccines
    Figure 10. Global Meningococcal Disease Treatment Market Share by Type in 2022 & 2028
    Figure 11. Global Meningococcal Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Meningococcal Disease Treatment Market Share by Type (2017-2028)
    Figure 13. United States Meningococcal Disease Treatment Market Share by Type in 2022 & 2028
    Figure 14. United States Meningococcal Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Meningococcal Disease Treatment Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Drugstores
    Figure 18. Product Picture of Others
    Figure 19. Global Meningococcal Disease Treatment Market Share by Application in 2022 & 2028
    Figure 20. Global Meningococcal Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Meningococcal Disease Treatment Market Share by Application (2017-2028)
    Figure 22. United States Meningococcal Disease Treatment Market Share by Application in 2022 & 2028
    Figure 23. United States Meningococcal Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Meningococcal Disease Treatment Market Share by Application (2017-2028)
    Figure 25. North America Meningococcal Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. United States Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Meningococcal Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Meningococcal Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. China Taiwan Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Meningococcal Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Meningococcal Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. UAE Meningococcal Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Pfizer Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 53. GlaxoSmithKline Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 54. Sanofi Pasteur Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 55. Novartis Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 56. CanSino Biologics Inc. Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 57. Merck Sharp & Dohme Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 58. Beijing Minhai Biological Technology Co.,Ltd. Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 59. Walvax Biotechnology Co.,Ltd. Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 60. Chengdu Institute of Biology Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 61. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 62. Shandong Jincheng Pharmaceutical Group Co.,ltd. Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 63. Apeloa Pharmaceutical Co.,Ltd. Revenue Growth Rate in Meningococcal Disease Treatment Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed